Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Quanta Pharma Retatrutide 50mg Specifications Retatrutide 50mg by Quanta Pharma Quanta Pharma Retatrutide Research Benefits Triple receptor action - Targets GLP-1, GIP, and Glucagon receptors for the most comprehensive metabolic research available Superior weight management - Clinical trials showed greater weight reduction compared to dual agonists like Tirzepatide Enhanced fat oxidation - Glucagon receptor activation promotes direct fat burning and energy expenditure Glycemic control - Researched for improving insulin sensitivity and glucose metabolism Extended half-life - Approximately 6 days allows for once-weekly administration in research protocols How Quanta Pharma Retatrutide Works Quanta Pharma Retatrutide is a triple agonist peptide that simultaneously activates three key receptors involved in metabolic regulation: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the Glucagon receptor
These effects are generally dose-dependent, with higher rates observed at the 2.4 mg weekly dose used for weight management compared to lower doses for diabetes
Insurance coverage for weight loss drugs remains highly variable and typically requires prior authorization and a BMI threshold
Request a savings offer If you have commercial insurancethe kind you get through work, or pay for yourselfyou may pay less for RYBELSUS with a savings offer.
US$ 28.45
US$ 29.83
US$ 24.05
US$ 29.89
US$ 29.69
